51 |
Comprehensive Metabolomic Analysis in Peanut Sensitization and Peanut-Induced Anaphylaxis: Discovery of Biomarkers and MediatorsKong, Joshua 29 August 2014 (has links)
<p>BACKGROUND: The ontogeny of peanut allergy (PA) is poorly understood, and the treatment of its most severe manifestation, peanut-induced anaphylaxis (PIA), remains limited to rescue epinephrine. We argued that an untargeted metabolomic analysis would be a useful hypothesis-generating tool to identify novel biomarkers, mediators and possibly therapeutic targets in PA and PIA.</p> <p>METHODS: Models of PA and PIA used in this thesis involved either the oral administration of peanut along with cholera toxin or the topical application of peanut on tape-stripped skin. Liquid-chromatography mass-spectrometry (LC-MS) was performed to identify chemical changes in the serum of mice undergoing sensitization and anaphylaxis. Flow cytometry as well as <em>in vivo</em> gain-of-function and loss-of-function immunological studies were used to determine the biological significance of particular molecules in sensitization.</p> <p>RESULTS: LC-MS followed by multivariant analysis showed that the purine metabolism pathway was altered with elevated levels of uric acid (UA) in sensitized mice. UA depletion using allopurinol and uricase fully prevented the development of the allergic and anaphylactic phenotype. Conversely, administration of UA crystals, instead of cholera toxin or tape stripping along with peanut induced a typical allergic and anaphylactic phenotype. The effects of UA and UA crystals are likely a consequence of effects on the activation of resident dendritic cells. Post-challenge metabolic analysis also revealed a distinct metabolic signature in sensitized mice, highlighted by an increase in several metabolites such as histamine. Likewise, peanut allergic patients display a distinct metabolic profile after oral peanut challenge.</p> <p>CONCLUSION: We identified UA, released after damage to the mucosa and/or skin, as a critical alarmin that facilitates the development of Th2 immunity, specifically PA and PIA. Metabolomics analyses of either mice undergoing anaphylaxis or peanut allergic children subjected to a peanut oral challenge provided an extensive overview of metabolomic changes underlying these conditions. Further studies may lead to the identification of novel biomarkers and mediators.</p> / Master of Science in Medical Sciences (MSMS)
|
52 |
The Role of Sugar-Sweetened Beverage Intake and Vitamin D in Elevated Systolic Blood PressureAbrams, Amanda 27 October 2017 (has links) (PDF)
High sugar-sweetened beverage (SSB) intake and poor vitamin D status have both been associated with increased risk of elevated systolic blood pressure (SBP) in previous research. However, these associations have never been investigated in the same study population, leaving the question of a possible interaction uninvestigated. One potential mechanism for an interaction is that SSB intake may increase serum uric acid (UA) and UA may interfere with utilization of vitamin D. This study examined these relationships in a sample of men and women (n=2,875) aged 20-74 using data collected in the 2003-2006 NHANES survey. No statistically significant association was found between SSB intake and risk of elevated SBP (defined as SBP>120mmHg) in whole group analysis. In subgroup analysis by gender, women (n=1,550) showed a 68% (OR: 1.68, 95% CI: 1.12-2.50, p-value 0.011) increased risk of elevated SBP in the highest SSB intake quartile (mean intake of 3.27 servings/day) compared to the lowest (mean intake of 0.03 servings/day) after adjustment for age, race, BMI, alcohol use, physical activity, and smoking, but no association was found in men (n=1,325). A statistically significant association was found between 25(OH)D and SBP, with a 30% decrease in risk of elevated SBP (OR: 0.70, 95% CI: 0.55-0.90, p-value 0.005) for those in the highest serum 25(OH)D group (>75nmol/L) compared to the lowest (<50nmol/L) in the fully adjusted model. However, no association was found between SSB intake and serum UA. Assessing potential effect modification between SSB and vitamin D in their impact on blood pressure using a multiplicative term and stratified analysis did not provided evidence of an interaction effect.
|
53 |
An investigation into the physiology of urate pellet excretion by Parcoblatta fulvescens (Saussure and Zehntner) (Dictyoptera: Blattellidae)Lembke, Hannah January 1985 (has links)
Physiological parameters involved in formed urate pellet excretion by the wood cockroach, <i>Parcoblatta fulvescens</i> were investigated.
Uric acid excretion by last instar juvenile <i>P. fulvescens</i> was studied first. Food consumption, urate and non-urate pellet excretion patterns show a skewed distribution with peak feeding occurring on day six and peak voiding of both pellet types on day seven of a 17.0 ± 2.0 (SD) day ecdysial cycle. The amount of urates excreted is determined by the level of dietary protein (p<0.0001) and is linearly related to protein consumption.
Selective feeding on protein, carbohydrate and cellulose diets by reproductive female <i>P. fulvescens</i> was investigated. Separate consumption patterns exist for each diet. These females did not excrete uric acid.
Urate pellet consumption by reproductive female <i>P. fulvescens</i> was examined in relation to dietary protein and carbohydrate. Urate pellet consumption increases with decreasing protein and increasing carbohydrate levels. Females that consume urate pellets do not excrete uric acid. These results suggest that urate-containing pellets serve to transfer nitrogen reserves among individuals.
Urate spherules were enzymatically and histochemically identified in the middle and proximal regions of the Malpighian tubules of <i>P. fulvescens</i>, <i>Shawella couloniana</i> and <i>Symploce hospes</i>. These spherules are discharged into the hindgut in sufficient quantities to obscure the presence of food residues.
The significance of formed urate pellet excretion is discussed in relation to the nitrogen economy of <i>Parcoblatta fulvescens</i>. / Master of Science / incomplete_metadata
|
54 |
High performance liquid chromatography (HPLC) in the investigation of gout in paleopathology.Swinson, D.J., Snaith, J., Buckberry, Jo, Brickley, M.B. January 2010 (has links)
No / Gout is a disease caused by the abnormal accumulation of uric acid in the body, which can
result in sodium urate crystals forming tophi at joints, with associated erosion of bone and
cartilage. Only two examples of tophi have been reported from archaeological individuals, and
the diagnosis of gout based on dry bone manifestations can be difficult. This paper presents
preliminary results of a new technique to aid the diagnosis of gout in palaeopathology, namely
high performance liquid chromatography (HPLC). Five archaeological skeletons with suspected
gout (diagnosed using visual and radiological analysis) and three controls were
analysed. Two of the gouty individuals had a white powder in their erosive lesions. HPLC
showed the presence of uric acid in bone in four of the five individuals with evidence of gouty
arthritis and was negative for uric acid in bone from the three controls. The white powder was
also positive for uric acid. With reliance on the presence of articular erosions, cases of gout will
be missed in archaeological human bone. HPLC measurement of uric acid could prove useful
in the differential diagnosis of erosive arthropathy in archaeology. It may also be useful in
identifying individuals with an increased body pool of uric acid, linked to conditions included in
the term `metabolic syndrome¿. As a result, HPLC uric acid measurement also has the potential
to provide additional information on health and lifestyle in past communities.
|
55 |
Associação do tratamento com alopurinol e desfechos definitivos em portadores de doença renal crônica com hiperuricemia assintomáticaValente, Luiz Eduardo January 2019 (has links)
Orientador: Luis Cuadrado Martin / Resumo: Fundamentação: É crescente o número de trabalhos revelando a associação de hiperuricemia assintomática com hipertensão, síndrome metabólica, doenças cardiovasculares e doença renal crônica. Alguns estudos revelam que o tratamento da hiperuricemia assintomática reduz o número de desfechos renais e cardiovasculares. Tal premissa, no entanto, ainda não foi avaliada em uma subpopulação brasileira. Objetivos: Avaliar a associação entre tratamento com alopurinol e ocorrência de desfechos definitivos em portadores de doença renal crônica com hiperuricemia assintomática. Materiais e métodos: Foram avaliados, de forma retrospectiva, pacientes hiperuricêmicos e portadores de doença renal crônica não dialítica, em tratamento no HC-FMB – UNESP, os quais iniciaram acompanhamento no ambulatório de Insuficiência Renal Crônica ou de Nefrologia Geral do HC-UNESP desde janeiro 2002 a dezembro 2017. Com o intuito de avaliar a associação do uso do alopurinol sobre desfechos definitivos (entrada em terapia renal substitutiva, duplicação da creatinina ou morte). Resultados: Foram avaliados 109 pacientes sendo 53 do sexo feminino, cuja média de idade foi de 68 ± 11 anos. Destes, 95 eram brancos, 13 afrodescendentes e um asiático. Vinte e seis pacientes apresentaram o desfecho estudado no período; entre todos os 36 pacientes que iniciaram o uso de alopurinol no primeiro ano seguimento, ocorreram oito desfechos (22%). A proteinúria em 24 h associou-se aos desfechos avaliados Hazzard Ratio de 1,301 (I... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Rationale: There is increasing number of studies revealing an association of hyperuricemia with hypertension, metabolic syndrome, cardiovascular diseases and chronic kidney disease. Some studies have shown that treatment of asymptomatic hyperuricemia reduces the number of renal and cardiovascular outcomes. This premise, however, has not yet been evaluated in a Brazilian subpopulation. Objectives: To evaluate the association between treatment with allopurinol and the occurrence of definitive outcomes in patients with chronic kidney disease with asymptomatic hyperuricemia. Materials and methods: Hyperuricemic patients with chronic non-dialytic kidney disease under treatment at HC-FMB - UNESP who began follow-up at the Chronic Kidney Insufficiency or General Nephrology outpatient clinic at HC-UNESP, were retrospectively evaluated, from January 2002 to December 2017. In order to evaluate the association of the use of allopurinol on definitive outcomes (renal replacement therapy, creatinine doubling or death). Results: A total of 109 patients were evaluated, of which 53 were females, whose mean age was 68 ± 11 years. Of these, 95 were white, 13 Afro-descendants and one Asian. Twenty-six patients presented the outcome studied in the period; among all 36 patients who started using allopurinol in the first year of follow-up, eight outcomes (22%) occurred. Proteinuria at 24 h was associated with the Hazzard Ratio of 1.301 (95% CI: 1.122 -1.508), p: 0.011. In univariate analysis, phosp... (Complete abstract click electronic access below) / Mestre
|
56 |
Participação de diferentes subtipos de macrófagos e a contribuição do ácido úrico solúvel, dos receptores TLR2 e TLR4 e das moléculas MyD88 e NLRP3 para o desenvolvimento da fibrose renal. / Involvement of different subtypes of macrophages and the contribution of soluble uric acid, the receptors TLR2 and TLR4 and MyD88 and NLRP3 molecules to the development of renal fibrosis.Braga, Tárcio Teodoro 16 June 2014 (has links)
A doença renal crônica é uma doença mediada pelo sistema imune e caracterizada por fibrose. Camundongos deficientes em TLR2, TLR4, MyD88 e NLRP3 se mostraram protegidos frente ao dano renal e à deposição de colágeno após serem submetidos à obstrução unilateral do ureter (UUO). Além disso, os camundongos protegidos exibiram menor produção de citocinas relacionadas com um perfil imune Th2 e apresentaram menor acúmulo de macrófagos do subtipo M2. Inicialmente, creditamos aos macrófagos M2 o papel de macrófagos formadores de fibrose uma vez que tal subpopulação é encontrada em maior número aos sete dias após a UUO em animais WT, porém, vimos que os personagens centrais no desenvolvimento da fibrose são macrófagos M1, encontrados no início da lesão renal. Também vimos que o ácido úrico é a molécula capaz de induzir a troca de fenótipo de M1 para M2 ao longo da UUO, além de ser capaz de ativar a via do inflamassoma. O ácido úrico solúvel é liberado em um contexto de hipóxia e ativa o complexo do inflamassoma NLRP3 por mecanismos diferentes, mas complementares. / Chronic kidney disease is an immune mediated disease characterized by fibrosis development. The damaged tissue releases molecules such as soluble uric acid resulting from the degradation of extracellular matrix or dead cells, which activate TLR and NLR, leading to the translocation of MyD88 in many cell types. This modulation of the immune system interferes with the activation of different subtypes of macrophages and activity of CD4+ T cells, with the Th1/Th2 paradigm as a possible effector mechanism of fibrosis. TLR2, TLR4, MyD88, and NLRP3 deficient mice are protected against renal damage and collagen deposition after being submitted to unilateral ureteral obstruction (UUO), when compared to wild type animals. Moreover, protected mice exhibited less production of Th2 related cytokines and reduced accumulation of M2 macrophages. Initially, we hypothesized M2 macrophages are responsible for fibrosis formation since this subset is found in greater numbers seven days after UUO in WT mice, however, we observed the central characters on the development of fibrosis are M1 macrophages found in the onset of renal injury. These data were confirmed by the injection of Stat6 KO M1 macrophages into Rag deficient mice previously depleted of macrophages and subjected to UUO, in which we observed higher proteinuria and increased collagen deposition. We also observed that uric acid is able to induce the exchange of phenotype from M1 to M2 along the UUO, besides being able to activate the inflammasome pathway. The soluble uric acid is released in the context of hypoxia and activates the NLRP3 inflammasome complex by different, but complementary mechanisms. Therefore, the renal damage releases soluble uric acid, which signals via innate immune receptors, and the damage brings as a consequence the deposition of proteins in the renal interstitium, culminating in fibrosis.
|
57 |
IMPACTO DA CIRURGIA BARIÁTRICA NA URICEMIA E NOS INDICADORES DE RISCO CARDIOVASCULAR EM MULHERES COM SÍNDROME METABÓLICA / IMPACT BARIATRIC SURGERY IN THE URICEMIA AND IN THE CARDIOVASCULAR RISK INDICATORS IN WOMEN WITH METABOLIC SYNDROMECâmara, Thalita de Albuquerque Véras 26 November 2014 (has links)
Made available in DSpace on 2016-08-19T18:16:09Z (GMT). No. of bitstreams: 1
Dissertacao THALITA DE ALBUQUERQUE VERAS.pdf: 1228117 bytes, checksum: ef9a2fea64bd1f59d9de3091281a24f4 (MD5)
Previous issue date: 2014-11-26 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Introduction: The association between hyperuricemia and cardiovascular risk factors, especially the metabolic syndrome and his components, has been widely documented. Despite of don t be a treatment directed to hyperuricemia, has been verified that, the bariatric surgery allowed to reach improvements on the acid uric metabolism. Methodology: It was accomplished an retrospective, observational, coorte and analytic study, through secondary data , women s with diagnosed metabolic syndrome according to the criterions of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III), 2001, underwent to Roux-en-Y gastric bypass mixed technique, in the period of january of 2012 to january of 2014. Of 391 medical records only 84 attempted to the selected sample criterions. It was collected the plasmatic acid uric values, the syndrome metabolic components and otters cardiovascular risk factors. Results: It was noticed a high prevalence of young adult woman s (27 to 34 years), 38,1% (32) , mean age to 33,5±10,1 years, with the mean Body Mass Index (BMI) levels to 39,3±4,3 Kg/m², degree II of obesity occurred with more often in 47,6% (40). The mean of triglycerides (TG) (202,1±92,8 mg/dL), diabetes glucose plasma (135,3±42,6 mg/dL), diastolic e systolic blood pressure, low density lipoprotein (LDL-c) (126,3± 30,5 mg/dL), very low density lipoprotein (VLDL-c) (41,2±19,2 mg/dL) all this data demonstrated an increase when the uric acid levels was ≥ 6 mg/dL, however there was a significant difference only to the variables triglycerides (p=0,0435) , of the hypertensives patients diastolic blood pressure (p=0,0413), and VLDL-c (p=0,0357). The only variable that was positively and significantly correlated (p =0,0026) with the uric acid was the systolic blood pressure, however demonstrated a weak correlation (r=0,3249). And those who presented uric acid level < 6mg/dL and 3, 4 e 5 aggregation of the metabolic syndrome components, the frequency was 100% (43), 77, 8% (21) and 35, 7% (5), respectively, demonstrating reduction of the frequency according with the inclusion of one more syndrome metabolic criteria. And on the cutoff ≥ 6mg/dL, that define hyperuricemia, occurred the opposite, and on the aggregation 4 and 5 the frequency was 22, 2% (6) and 66, 3% (9), and none of the participant with hyperuricemia on the aggregation 3. Conclusion: Surgery for Gastric Bypass Roux-Y was able to reduce the levels of uric acid and cardiometabolic control, including the metabolic syndrome. / Introdução: A associação entre os níveis de ácido úrico e fatores de risco cardiovascular, especialmente, na síndrome metabólica e com seus componentes tem sido amplamente documentada. Apesar de não ser um tratamento dirigido à hiperuricemia, tem sido verificado que a cirurgia bariátrica permite alcançar uma melhoria no metabolismo do ácido úrico. Objetivo: Verificar o impacto da cirurgia bariátrica na uricemia e nos indicadores de risco cardiovascular, e associação, em mulheres com síndrome metabólica. Metodologia: Foi realizado um estudo retrospectivo, observacional do tipo coorte e analítico com coleta de dados secundários de mulheres com Síndrome Metabólica, diagnosticadas de acordo com os critérios do Programa Nacional de Educação sobre Colesterol, ligado ao III Painel de Tratamento do Adulto (NCEP-ATP III), 2001, submetidas à cirurgia bariátrica pela técnica mista do bypass gástrico em Y de Roux, no período de janeiro de 2012 a janeiro de 2014. De 391 prontuários, apenas 84 atenderam aos critérios de seleção da amostra. Foram coletados valores de ácido úrico plasmático, componentes da síndrome metabólica e outros fatores de risco cardiovascular. Resultados: Notou-se elevada prevalência de mulheres adultas jovens (faixa de 27 a 34 anos), 38,1% (32), média de idade de 33,5±10,1 anos, Índice de Massa Corporal (IMC) com média de 39,3±4,3kg/m² e grau II de obesidade foi o mais frequente, 47,6% (40). Demonstrou-se que as médias de triglicerídeos (202,1±92,8 mg/dL), glicemia das diabéticas (135,3±42,6 mg/dL), pressão arterial sistólica e diastólica, lipoproteína de baixa densidade (LDL-c) (126,3±30,5 mg/dL), e lipoproteínas de muito baixa densidade (VLDL-c) (41,2±19,2 mg/dL) foram mais elevadas quando os níveis de ácido úrico estavam ≥ 6mg/dL, no entanto, houve diferença significativa apenas para as variáveis triglicerídeos (p=0,0435), pressão arterial diastólica das hipertensas (p=0,0413) e VLDL-c (p=0,0357). E, aquelas que apresentaram níveis de ácido úrico < 6mg/dL e aglomerado 3, 4 e 5 de componentes da SM, a frequência foi de 100% (43), 77,8% (21) e 35,7% (5), respectivamente, mostrando redução da frequência de acordo com a inclusão de mais um critério da síndrome metabólica. No ponto de corte ≥ 6 mg/dl, que determina a hiperuricemia, ocorreu o inverso, no aglomerado 4 e 5 a frequência foi de 22,2% (6) e 64,3% (9), e nenhuma participante com hiperuricemia no aglomerado 3. Conclusão: A cirurgia do bypass gástrico em Y de Roux foi capaz de reduzir os níveis de ácido úrico e controle cardiometabolico, incluindo a Síndrome Metabólica.
|
58 |
Impacto da cirurgia bariátrica na uricemia e nos indicadores de risco cardiovascular em mulheres com síndrome metabólica / IMPACT BARIATRIC SURGERY IN THE URICEMIA AND IN THE CARDIOVASCULAR RISK INDICATORS IN WOMEN WITH METABOLIC SYNDROMECâmara , Thalita de Albuquerque Véras 26 November 2014 (has links)
Submitted by Rosivalda Pereira (mrs.pereira@ufma.br) on 2017-05-17T18:34:39Z
No. of bitstreams: 1
ThalitaCamara.pdf: 1228117 bytes, checksum: ef9a2fea64bd1f59d9de3091281a24f4 (MD5) / Made available in DSpace on 2017-05-17T18:34:39Z (GMT). No. of bitstreams: 1
ThalitaCamara.pdf: 1228117 bytes, checksum: ef9a2fea64bd1f59d9de3091281a24f4 (MD5)
Previous issue date: 2014-11-26 / Introduction: The association between hyperuricemia and cardiovascular risk factors, especially the metabolic syndrome and his components, has been widely documented. Despite of don’t be a treatment directed to hyperuricemia, has been verified that, the bariatric surgery allowed to reach improvements on the acid uric metabolism. Methodology: It was accomplished an retrospective, observational, coorte and analytic study, through secondary data , women’s with diagnosed metabolic syndrome according to the criterions of the National Cholesterol Education Program Adult Treatment Panel – III (NCEP-ATP III), 2001, underwent to Roux-en-Y gastric bypass mixed technique, in the period of january of 2012 to january of 2014. Of 391 medical records only 84 attempted to the selected sample criterions. It was collected the plasmatic acid uric values, the syndrome metabolic components and otters cardiovascular risk factors. Results: It was noticed a high prevalence of young adult woman’s (27 to 34 years), 38,1% (32) , mean age to 33,5±10,1 years, with the mean Body Mass Index (BMI) levels to 39,3±4,3 Kg/m², degree II of obesity occurred with more often in 47,6% (40). The mean of triglycerides (TG) (202,1±92,8 mg/dL), diabetes glucose plasma (135,3±42,6 mg/dL), diastolic e systolic blood pressure, low density lipoprotein (LDL-c) (126,3± 30,5 mg/dL), very low density lipoprotein (VLDL-c) (41,2±19,2 mg/dL) all this data demonstrated an increase when the uric acid levels was ≥ 6 mg/dL, however there was a significant difference only to the variables triglycerides (p=0,0435) , of the hypertensives patients diastolic blood pressure (p=0,0413), and VLDL-c (p=0,0357). The only variable that was positively and significantly correlated (p =0,0026) with the uric acid was the systolic blood pressure, however demonstrated a weak correlation (r=0,3249). And those who presented uric acid level < 6mg/dL and 3, 4 e 5 aggregation of the metabolic syndrome components, the frequency was 100% (43), 77, 8% (21) and 35, 7% (5), respectively, demonstrating reduction of the frequency according with the inclusion of one more syndrome metabolic criteria. And on the cutoff ≥ 6mg/dL, that define hyperuricemia, occurred the opposite, and on the aggregation 4 and 5 the frequency was 22, 2% (6) and 66, 3% (9), and none of the participant with hyperuricemia on the aggregation 3. Conclusion: Surgery for Gastric Bypass Roux-Y was able to reduce the levels of uric acid and cardiometabolic control, including the metabolic syndrome. / ntrodução: A associação entre os níveis de ácido úrico e fatores de risco cardiovascular, especialmente, na síndrome metabólica e com seus componentes tem sido amplamente documentada. Apesar de não ser um tratamento dirigido à hiperuricemia, tem sido verificado que a cirurgia bariátrica permite alcançar uma melhoria no metabolismo do ácido úrico. Objetivo: Verificar o impacto da cirurgia bariátrica na uricemia e nos indicadores de risco cardiovascular, e associação, em mulheres com síndrome metabólica. Metodologia: Foi realizado um estudo retrospectivo, observacional do tipo coorte e analítico com coleta de dados secundários de mulheres com Síndrome Metabólica, diagnosticadas de acordo com os critérios do Programa Nacional de Educação sobre Colesterol, ligado ao III Painel de Tratamento do Adulto (NCEP-ATP III), 2001, submetidas à cirurgia bariátrica pela técnica mista do bypass gástrico em Y de Roux, no período de janeiro de 2012 a janeiro de 2014. De 391 prontuários, apenas 84 atenderam aos critérios de seleção da amostra. Foram coletados valores de ácido úrico plasmático, componentes da síndrome metabólica e outros fatores de risco cardiovascular. Resultados: Notou-se elevada prevalência de mulheres adultas jovens (faixa de 27 a 34 anos), 38,1% (32), média de idade de 33,5±10,1 anos, Índice de Massa Corporal (IMC) com média de 39,3±4,3kg/m² e grau II de obesidade foi o mais frequente, 47,6% (40). Demonstrou-se que as médias de triglicerídeos (202,1±92,8 mg/dL), glicemia das diabéticas (135,3±42,6 mg/dL), pressão arterial sistólica e diastólica, lipoproteína de baixa densidade (LDL-c) (126,3±30,5 mg/dL), e lipoproteínas de muito baixa densidade (VLDL-c) (41,2±19,2 mg/dL) foram mais elevadas quando os níveis de ácido úrico estavam ≥ 6mg/dL, no entanto, houve diferença significativa apenas para as variáveis triglicerídeos (p=0,0435), pressão arterial diastólica das hipertensas (p=0,0413) e VLDL-c (p=0,0357). E, aquelas que apresentaram níveis de ácido úrico < 6mg/dL e aglomerado 3, 4 e 5 de componentes da SM, a frequência foi de 100% (43), 77,8% (21) e 35,7% (5), respectivamente, mostrando redução da frequência de acordo com a inclusão de mais um critério da síndrome metabólica. No ponto de corte ≥ 6 mg/dl, que determina a hiperuricemia, ocorreu o inverso, no aglomerado 4 e 5 a frequência foi de 22,2% (6) e 64,3% (9), e nenhuma participante com hiperuricemia no aglomerado 3. Conclusão: A cirurgia do bypass gástrico em Y de Roux foi capaz de reduzir os níveis de ácido úrico e controle cardiometabolico, incluindo a Síndrome Metabólica.
|
59 |
Aumento da atividade dos sistemas antioxidantes modula o estresse oxidativo na saliva de crianças com cárie precoce severa / Increased activity of antioxidant systems modulates the oxidative stress in saliva of children with severe early cariesSilva, Priscila Vieira da [UNESP] 31 March 2016 (has links)
Submitted by PRISCILA VIEIRA DA SILVA null (privieira.odonto@gmail.com) on 2016-05-16T16:04:00Z
No. of bitstreams: 1
Dissertação Priscila Vieira da Silva.pdf: 1090391 bytes, checksum: 41dc10fe589d791d5b3020f707074cbe (MD5) / Approved for entry into archive by Ana Paula Grisoto (grisotoana@reitoria.unesp.br) on 2016-05-17T14:57:14Z (GMT) No. of bitstreams: 1
silva_pv_me_araca.pdf: 1090391 bytes, checksum: 41dc10fe589d791d5b3020f707074cbe (MD5) / Made available in DSpace on 2016-05-17T14:57:14Z (GMT). No. of bitstreams: 1
silva_pv_me_araca.pdf: 1090391 bytes, checksum: 41dc10fe589d791d5b3020f707074cbe (MD5)
Previous issue date: 2016-03-31 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / O estresse oxidativo é atribuído a um desequilíbrio entre a ação de sistemas antioxidantes com a produção exacerbada de radicais livres, como espécies reativas de oxigênio. A atividade dos sistemas antioxidantes enzimáticos e não enzimáticos, são uma poderosa defesa do corpo contra danos causados pelos radicais livres. Biomarcadores do estresse oxidativo podem ser observados na saliva de adultos e crianças. O objetivo deste trabalho foi avaliar os níveis de estresse oxidativo e a atividade de sistema antioxidante enzimático, como a superóxido dismutase (SOD) e não-enzimático como o ácido úrico (AU) na saliva de crianças na primeira infância (0-3 anos de idade) que apresentaram cárie precoce severa da infância (S-ECC do inglês, severe early childhood caries). Amostras de saliva não estimuladas foram coletadas pela manhã, durante 5 minutos, usando o Salivette® em crianças de 0-3 anos de idade, com cárie precoce severa na infância (n = 30) e em crianças livres de cárie (n = 30) de escolas públicas de Araçatuba – SP. Foram feitas as avaliações de estresse oxidativo (EO), pela medida da peroxidação lipídica, da capacidade antioxidante total (CAT), pelo método FRAP, bem como de sistema antioxidante enzimático, avaliando a atividade da SOD e não enzimático pela avaliação do UA, salivares. Os dados foram analisados por programa estatístico Graph Pad Prism, versão 5.0 e comparados pelo teste t de Student (p <0,05). Níveis de proteína elevados foram observados na saliva de crianças S-ECC quando comparados ao grupo livre de cárie. O dano oxidativo foi menor na saliva de S-ECC, enquanto a CAT salivar, atividade da SOD e ácido úrico salivares foram mais elevados em S-ECC quando comparados ao grupo livre de cárie. Nosso estudo demonstrou que o menor dano oxidativo observado na saliva de S-ECC estaria associado ao aumento da atividade de sistemas antioxidantes enzimático e não enzimático. / Oxidative stress is attributed to an imbalance between the antioxidant systems activity and the increased production of free radicals such as reactive oxygen species. The activity of enzymatic and non-enzymatic antioxidant systems are a powerful defense of the body against damage caused by free radicals. Oxidative stress biomarkers can be observed in the saliva of adults and children. The objective of this study was to evaluate the levels of oxidative stress and antioxidant enzyme system activity, such as superoxide dismutase (SOD) and nonenzymatic as uric acid (UA) in the saliva of toddlers (0-3 years old) with severe early childhood caries (S-ECC). Unstimulated saliva samples were collected in the morning during 5 minutes using Salivette® in S-ECC children (n = 30) and in caries-free children (n = 30) of public schools in Araçatuba - SP. We evaluated the salivary protein level by Lowry method, and the oxidative stress (OS) by lipid peroxidation. The total antioxidant capacity (TAC) was analyzed by FRAP method. The activity of salivary SOD and salivary UA were assessed as enzymatic and non-enzymatic antioxidant systems, respectively. Data were analyzed by statistical program Graphpad Prism version 5.0 and the results were compared between groups by Student's t test (p <0.05). High protein levels were observed in the saliva of S-ECC children when compared to caries-free group. Oxidative damage was lower in S-ECC group, while the salivary TAC, SOD activity and salivary UA were higher in S-ECC when compared to the caries-free group. This study demonstrated that decreased oxidative damage was associated with the increased activities of the enzymatic and non-enzymatic antioxidant systems in S-ECC saliva.
|
60 |
Análise dos níveis de carboidratos e ácido úrico na hemolinfa de Pomacea lineata (Spix, 1827) em estivação induzida e sua influência sobre a histologia gonadalMACIEL, Gyl Everson de Souza 26 February 2013 (has links)
Submitted by (edna.saturno@ufrpe.br) on 2016-07-21T15:16:08Z
No. of bitstreams: 1
Gyl Everson de Souza Maciel.pdf: 1066870 bytes, checksum: 5d3e6cb058a19d66e3669721aeb1a30a (MD5) / Made available in DSpace on 2016-07-21T15:16:08Z (GMT). No. of bitstreams: 1
Gyl Everson de Souza Maciel.pdf: 1066870 bytes, checksum: 5d3e6cb058a19d66e3669721aeb1a30a (MD5)
Previous issue date: 2013-02-26 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Pomacea lineata (Spix, 1827) during the dry season buries itself in the ground and survives thanks to its ability to aestivation. Studies have shown that during aestivation levels of carbohydrates and uric acid, may provide more accurate information about the activity of the gonads in response to environmental stress. Thus, we tested the hypothesis that variations in the levels of uric acid and carbohydrate during aestivation induced, can affect gonadal histology and gametogenesis in P. lineata. The snails underwent aestivation of three, five and 10 months. Testes and ovaries were collected and processed for histological analysis. The results showed significant increase in the levels of uric acid and carbohydrates in proportion to the period of aestivation, and histological changes in the gonads. Thus, we conclude that the metabolism of proteins is proportional to the period of aestivation for carbohydrate synthesis and excretion of uric acid, thereby ensuring the integrity of the reproductive tract. / Pomacea lineata (Spix, 1827)durante a época de estiagem se enterra no solo e sobrevive graças a sua capacidade de estivação. Estudos têm mostrado que durante a estivação os níveis de carboidratos e ácido úrico, podem fornecer informações mais precisas sobre a atividade das gônadas em resposta ao estresse ambiental. Assim, testou-se a hipótese de que as variações nos níveis de carboidratos e acido úrico, durante a estivação induzida, pode afetar a histologia gonadal e gametogênese em P. lineata. Os caramujos foram submetidos à estivação por três, cinco e 10 meses. Testículos e ovários foram coletados e processados para análises histológicas. Os resultados mostraram aumento significativo dos níveis de carboidratos e ácido úrico proporcionalmente ao período de estivação, além de alterações histológicas nas gônadas. Assim, concluímos que a metabolização de proteínas é proporcional ao período de estivação, para síntese de carboidratos e excreção de ácido úrico, garantindo assim, a integridade do aparelho reprodutor.
|
Page generated in 0.0662 seconds